Skip to main content
Veterinary Medicines

TAbic IB VAR206, effervescent tablets for suspension for chickens

Authorised
  • Avian infectious bronchitis virus, strain 2-06, Live

Product identification

Medicine name:
TAbic IB VAR206, effervescent tablets for suspension for chickens
TAbic IB VAR206, šnypščiosios tabletės suspensijai ruošti vištoms.
Active substance:
  • Avian infectious bronchitis virus, strain 2-06, Live
Target species:
  • Chicken (hen)
Route of administration:
  • Nebulisation use

Product details

Active substance and strength:
  • Avian infectious bronchitis virus, strain 2-06, Live
Pharmaceutical form:
  • Effervescent tablet
Withdrawal period by route of administration:
  • Nebulisation use
    • Chicken (hen)
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI01AD07
Authorisation status:
  • Valid
Authorised in:
  • Lithuania
Available in:
  • Lithuania
Package description:
  • Tablets (500 doses) are packed in Aluminium – Aluminium blisters: Alum Soft Silver (PVC/PVDC) – Alum Silver (PVC). Each blister contains 10 tablets. Cardboard box contains 1 blister.
  • Tablets (1000 doses) are packed in Aluminium – Aluminium blisters: Alum Soft Silver (PVC/PVDC) – Alum Silver (PVC). Each blister contains 10 tablets. Cardboard box contains 2 blisters.
  • Tablets (2500 doses) are packed in Aluminium – Aluminium blisters: Alum Soft Silver (PVC/PVDC) – Alum Silver (PVC). Each blister contains 10 tablets. Cardboard box contains 2 blisters.
  • Tablets (1000 doses) are packed in Aluminium – Aluminium blisters: Alum Soft Silver (PVC/PVDC) – Alum Silver (PVC). Each blister contains 10 tablets. Cardboard box contains 1 blister.
  • Tablets (10 000 doses) are packed in Aluminium – Aluminium blisters: Alum Soft Silver (PVC/PVDC) – Alum Silver (PVC). Each blister contains 10 tablets. Cardboard box contains 2 blisters.
  • Tablets (5000 doses) are packed in Aluminium – Aluminium blisters: Alum Soft Silver (PVC/PVDC) – Alum Silver (PVC). Each blister contains 10 tablets. Cardboard box contains 1 blister.
  • Tablets (2000 doses) are packed in Aluminium – Aluminium blisters: Alum Soft Silver (PVC/PVDC) – Alum Silver (PVC). Each blister contains 10 tablets. Cardboard box contains 2 blisters.
  • Tablets (10 000 doses) are packed in Aluminium – Aluminium blisters: Alum Soft Silver (PVC/PVDC) – Alum Silver (PVC). Each blister contains 10 tablets. Cardboard box contains 1 blister.
  • Tablets (500 doses) are packed in Aluminium – Aluminium blisters: Alum Soft Silver (PVC/PVDC) – Alum Silver (PVC). Each blister contains 10 tablets. Cardboard box contains 1 blister.
  • Tablets (2000 doses) are packed in Aluminium – Aluminium blisters: Alum Soft Silver (PVC/PVDC) – Alum Silver (PVC). Each blister contains 10 tablets. Cardboard box contains 1 blister.
  • Tablets (2500 doses) are packed in Aluminium – Aluminium blisters: Alum Soft Silver (PVC/PVDC) – Alum Silver (PVC). Each blister contains 10 tablets. Cardboard box contains 1 blister.
  • Tablets (5000 doses) are packed in Aluminium – Aluminium blisters: Alum Soft Silver (PVC/PVDC) – Alum Silver (PVC). Each blister contains 10 tablets. Cardboard box contains 2 blisters.

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Phibro Animal Health (Poland) Sp. z o.o.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Synoptis Industrial Sp. z o.o.
Responsible authority:
  • State Food And Veterinary Service
Authorisation number:
  • LT/2/20/2570/001-012
Date of authorisation status change:
Reference member state:
  • Poland
Procedure number:
  • PL/V/0109/001/MR
Concerned member states:
  • Bulgaria
  • Czechia
  • Latvia
  • Lithuania
  • Romania
  • Slovakia
  • Slovenia

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Lithuanian (PDF)
Published on: 26/09/2023

Combined File of all Documents

English (PDF)
Published on: 7/02/2024
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."